JXSB2200032 | sacituzumab govitecan | | Injection | Biological Products(2.2) | Supplementary Application | 2022-03-18 | | Everest Medicines II(HK)Ltd;BSP Pharmaceuticals Srl | | | view |
JXSB2101085 | sacituzumab govitecan | | Injection | Biological Products(3.1) | Supplementary Application | 2021-11-09 | | Everest Medicines II(HK)Ltd;BSP Pharmaceuticals Srl | | | view |
JTS2100023 | sacituzumab govitecan | | Injection | Biological Products | Disposable Import Drug Application | 2021-03-08 | BSP Pharmaceuticals S.p.A. | BSP Pharmaceuticals Srl;Everest Medicines (Suzhou) Inc;Immunomedics Inc | Certificate Issued | 2021-04-01 | view |
JXSB2100015 | sacituzumab govitecan | | Injection | Biological Products(2.2) | Supplementary Application | 2021-02-23 | 云顶药业(苏州)有限公司 | Everest Medicines (Suzhou) Inc;Everest Medicines II(HK)Ltd;BSP Pharmaceuticals Srl | In Review | 2021-02-22 | view |
JTS2100016 | sacituzumab govitecan | | Injection | Biological Products | Disposable Import Drug Application | 2021-02-02 | BSP Pharmaceuticals S.p.A. | BSP Pharmaceuticals Srl;Everest Medicines (Suzhou) Inc;Immunomedics Inc | Certificate Issued | 2021-02-26 | view |
JXSL2100007 | sacituzumab govitecan | | Injection | Biological Products(2.2) | Import Drug Application | 2021-01-13 | 云顶药业(苏州)有限公司 | Everest Medicines (Suzhou) Inc;Everest Medicines II(HK)Ltd | In Review | 2021-01-12 | view |
JXSL2000182 | sacituzumab govitecan | | Injection | Biological Products(2.2) | Import Drug Application | 2020-10-15 | 云顶药业(苏州)有限公司 | Everest Medicines (Suzhou) Inc;Everest Medicines II(HK)Ltd | In Review | 2020-10-14 | view |
JXSL2000144 | sacituzumab govitecan | | Injection | Biological Products(2.2) | Import Drug Application | 2020-08-26 | 云顶药业(苏州)有限公司 | Everest Medicines (Suzhou) Inc;Everest Medicines II(HK)Ltd | In Review | 2020-08-25 | view |
JXSL2000014 | sacituzumab govitecan | | Injection | Biological Products | Import Drug Application | 2020-01-22 | 云顶药业(苏州)有限公司 | Everest Medicines (Suzhou) Inc;Everest Medicines II(HK)Ltd | In Review | 2020-01-21 | view |